Von willebrand factor

Vonvendi

1300IU For InjectionUnited StatesMarketedAuthorised 8 Dec 2015

In other countries

The same active substances on other registers, the same brand first.

VonvendiCanada · 650 UNIT / VIAL · Powder For Solution · Takeda Canada INCSame brand
VonvendiCanada · 1300 UNIT / VIAL · Powder For Solution · Takeda Canada INCSame brand
Willfact 1000 Ui Polvo y Disolvente Para Solucion InyectableSpain · 1000 UI · polvo y disolvente para solución inyectable · Lfb BiomedicamentsSame form
Willfact 2000 Ui Polvo y Disolvente Para Solucion InyectableSpain · 2000 UI · polvo y disolvente para solución inyectable · Lfb BiomedicamentsSame form
Willfact 500 Ui Polvo y Disolvente Para Solucion InyectableSpain · 500 UI · polvo y disolvente para solución inyectable · Lfb BiomedicamentsSame form
VeyvondiItaly · Polvere e solvente per soluzione iniettabile · Baxalta Innovations GMBHSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Von willebrand factor

Vonvendi

1300IU For InjectionUnited StatesMarketedAuthorised 8 Dec 2015

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

VEYVONDI 1300 IE poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Baxalta Innovations GmbH

VEYVONDI 650 IE poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Baxalta Innovations GmbH

Wilfactin 100 IE/ml, poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Laboratoire Francais du Fractionnement et des Biotechnologies (LFB Biomedicaments)

VeyvondiEuropean Union · Baxalta Innovations GmbH

VeyvondiCroatia

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Von willebrand factor
Strength: 1300IU
Dosage form: For Injection
Route: Intravenous
Register: United States (FDA)
Status: Marketed
Status in the register: Licensed / Rx
Authorised: 8 Dec 2015
Registration: BLA 125577
Marketing authorisation holder: Takeda Pharmaceuticals U.S.A., Inc.
Procedure: 351(a)
Supply: Rx